Evidence map›Paper›PMID 39269008›Full record

SynthesisJournal of the European Academy of Dermatology and Venereology : JEADV2025

The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review.

J Vyas, J R Johns, Y Abdelrazik, F M Ali, J R Ingram, S Salek, A Y Finlay

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Internalized stigma, not disability, drives quality-of-life loss in leprosy: A structural analysis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  6. Development and psychometric evaluation of a new itch assessment questionnaire for use in multi-ethnic Asian population.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  7. Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trials.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Nomogram Predicting Decreased Quality of Life in Patients with Keloids.Clinical, cosmetic and investigational dermatology · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J VyasCentre for Medical Education, School of Medicine, Cardiff University, Cardiff, UK.
J R JohnsDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.ORCID https://orcid.org/0000-0002-1628-4306
Y AbdelrazikUniversity Hospitals Birmingham, NHS Foundation Trust, Birmingham, UK.
F M AliDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
J R IngramDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
S SalekSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
A Y FinlayDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.ORCID https://orcid.org/0000-0003-2143-1646

Funding

Division of Infection and Immunity, School of Medicine, Cardiff University
6 · The paper itself

Abstract

backgroundThe validation of psychometric measures requires use of other established and standardized validated measures. The Dermatology Life Quality Index (DLQI) is the most widely used tool to measure the burden of skin diseases and assess effectiveness of interventions based on patients' perspective.

objectivesThe objective of this study was to systematically analyse peer-reviewed publications describing use of the DLQI in validation of other patient-reported outcome (PRO) and quality-of-life (QoL) measures.

methodsSeven databases were searched for papers published between January 1994 and December 2022 for articles containing data using DLQI in the validation of other PRO/QoL measures. The methodology followed PRISMA guidelines. The protocol was prospectively registered on PROSPERO.

resultsOf 1717 screened publications, 122 articles including 30,727 patients from 34 different countries with 41 diseases met the inclusion criteria. The DLQI was used in validation of 101 measures: 80 dermatology-specific QoL measures, mostly disease-specific, and 21 generic measures. Of these studies, 47 were cross-cultural adaptations, 116 single arm, 100 were cross-sectional, 18 longitudinal and six randomized placebo controlled. DLQI was used for 14 known group, and correlation for 10 construct, 101 convergent, 10 concurrent, 10 divergent/discriminant and three criterion validity tests using Mann-Whitney (2), Spearman's (80), Pearson's correlation (26) and Student's t-test (1). The DLQI was used in responsiveness analysis in 13 studies.

conclusionsThis review identified widespread use of the DLQI in validation of other dermatology PRO/QoL measures and confirmed the central role that the DLQI plays as a benchmark in instrument development and validation across dermatology and beyond. The use of the DLQI by so many developers of other instruments has provided a common standard for comparability.

Indexed as

DermatologyPatient Reported Outcome MeasuresQuality of LifeSkin DiseasesBenchmarkingHumansPsychometricsReproducibility of Results

Identifiers

PMID39269008
PMCPMC11851266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.